Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |